2Seventy Bio Inc (TSVT) — Financial Flexibility Index
2Seventy Bio Inc (TSVT) has a Financial Flexibility Index of -0.04x as of March 2025. Free cash flow of $-10.97 Million (operating CF $-10.97 Million minus capex $0.00) represents 0% of total liabilities ($266.04 Million). Check TSVT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
2Seventy Bio Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for 2Seventy Bio Inc across 6 annual periods. See 2Seventy Bio Inc (TSVT) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for 2Seventy Bio Inc (2019–2024)
Year-by-year free cash flow to debt coverage for 2Seventy Bio Inc. For the full company profile including market capitalisation, see 2Seventy Bio Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.31x | $-84.29 Million | $-85.00 Million | $268.70 Million | ▲ +36.4% |
| 2023 | -0.49x | $-152.99 Million | $-166.86 Million | $310.13 Million | ▲ +20.3% |
| 2022 | -0.62x | $-214.29 Million | $-237.13 Million | $346.20 Million | ▼ -32.0% |
| 2021 | -0.47x | $-187.46 Million | $-207.03 Million | $399.85 Million | ▼ -145.0% |
| 2020 | -0.19x | $-45.53 Million | $-67.79 Million | $237.99 Million | ▲ +65.0% |
| 2019 | -0.55x | $-148.19 Million | $-207.96 Million | $271.26 Million | — |